Abstract

It is a well established fact that cardiac health and exercise go hand in hand. However, rigorous exercising regimens without proper cardiovascular screening can lead to catastrophic death in unsuspecting and otherwise healthy individuals. Among the underlying undetected cardiovascular conditions that need to be accounted for, especially in young adults, are hypertrophic cardiomyopathies. The deceased, a 33-year-old state level bodybuilder, was participating in a body building competition when he suddenly complained of dizziness and collapsed. The deceased appeared to have no signifi cant fi ndings on external examination. Internal examination, however, revealed that the heart was enlarged and weighed 698 g. On microscopic examination, ventricle sections showed enlarged myocytes with disarray and enlarged nuclei. The cause of death was ascertained to be due to complications of hypertrophic cardiomyopathy. Among the feasible options available in low and middle income countries, electrocardiography is an inexpensive method as a screening test, leading the way for using tools such as CMR, serum biomarkers and genetic testing if required. Understanding the relationship between physical exertion and its eff ect on a hypertrophic heart is essential. The case presented brings to light the need for in-depth precompetition screening of athletes. This is especially true since athletes are the one category of individuals where good health is taken for granted.

• 1.   Nystoriak MA, Bhatnagar A. Cardiovascular effects and benefits of exercise. Frontiers in cardiovascular medicine. 2018 Sep 28;5:135.
• 2.   Paffenbarger Jr RS, Hyde R, Wing AL, Hsieh CC. Physical activity, all-cause mortality, and longevity of college alumni. New England journal of medicine. 1986 Mar 6;314(10):605-13.
• 3.   Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 1995 Aug 15;92(4):785- 9.
• 4.   Maron MS, Hellawell JL, Lucove JC, Farzaneh-Far R, Olivotto I. Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States. The American journal of cardiology. 2016 May 15;117(10):1651-4.
• 5.   Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2015 Mar 31;65(12):1249-54.
• 6.   Kumar V, Abbas A, Aster J. Robbins & Cotran Pathologic Basis of Disease: South Asian Edition. 1st ed. Vol. 1. Elsevier India; 1st edition (14 August 2014); 2014. 568-569 p.
• 7.   Vora A, Burkule N, Contractor A, Bhargava K. Prevention of sudden cardiac death in athletes, sportspersons and marathoners in India. Indian heart journal. 2018 Jan 1;70(1):137-45.
• 8.   Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. Journal of the American college of cardiology. 2013 Mar 12;61(10):1027- 40.
• 9.   Corrado D, Schmied C, Basso C, Borjesson M, Schiavon M, Pelliccia A, Vanhees L, Thiene G. Risk of sports: do we need a preparticipation screening for competitive and leisure athletes?. European heart journal. 2011 Apr 2;32(8):934-44.

Data Sharing Statement

Funding